Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic

Document Type

Journal Article

Publication Title

JCO Oncology Practice

Volume

16

Issue

8

First Page

467

Last Page

482

PubMed ID

32401686

Publisher

American Society of Clinical Oncology

School

School of Medical and Health Sciences

RAS ID

35238

Funders

https://ascopubs.org/doi/10.1200/OP.20.00229

Comments

Segelov, E., Underhill, C., Prenen, H., Karapetis, C., Jackson, C., Nott, L., ... & Raina MacIntyre, C. (2020). Practical considerations for treating patients with cancer in the COVID-19 pandemic. JCO Oncology Practice, 16(8), 467-482. https://doi.org/10.1200/OP.20.00229

Abstract

Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.

DOI

10.1200/OP.20.00229

Access Rights

free_to_read

Link to Full Text

Share

 
COinS